Proto Labs, Inc. — 2016 Form 10-K
Business and period: Proto Labs is an e-commerce-driven manufacturer of custom parts for prototyping and short-run production, using injection molding, CNC machining and 3D printing. This filing reports the year ended December 31, 2016; it is an annual report, not a standalone fourth-quarter filing. Amounts below are in millions of dollars unless noted.
Financial performance and liquidity
| Metric | 2016 | 2015 |
|---|---|---|
| Revenue | $298.1 | $264.1 |
| Gross profit / margin | $166.9 / 56.0% | $154.4 / 58.5% |
| Operating income / margin | $61.8 / 20.7% | $67.1 / 25.5% |
| Net income / diluted EPS | $42.7 / $1.61 | $46.5 / $1.77 |
| Cash from operating activities | $75.0 | $58.6 |
| Capital expenditures | $33.6 | $44.4 |
| Cash and cash equivalents at year-end | $68.8 | $47.7 |
- Cash and marketable securities totaled $192.8 at year-end 2016. Working capital was $134.4; total liabilities were $34.4, and the company reported no debt or financing arrangements.
- 2016 revenue grew 12.9%, but operating income fell 8.0% and net income fell 8.2%. Gross margin declined 2.5 percentage points.
- Fourth-quarter 2016 revenue was $72.4, operating income $14.8, net income $9.4 and diluted EPS $0.35. In Q4 2015, revenue was $73.8, operating income $16.6, net income $12.0 and diluted EPS $0.45.
Changes and operating trends
- Growth was broad-based: U.S. revenue rose 7.6%, Europe 33.6% and Japan 24.3%. Europe’s growth was partly attributable to the 2015 Alphaform acquisition.
- By product line, injection molding revenue increased 7.7%, CNC machining 9.5% and 3D printing 50.6%. 3D printing represented 12.7% of revenue, up from 9.5%.
- The company served 31,457 unique product developers and engineers, up 15.5%, while average revenue per developer or engineer declined 6%. Existing customers generated 67% of revenue, versus 85% in 2015.
- Cost of revenue rose 19.5%, faster than sales, reflecting higher material and production costs, labor, capacity investment, Alphaform and $0.6 of accelerated depreciation. Lower-margin acquired operations and capacity investments contributed to margin pressure.
- Marketing and sales, R&D, and general and administrative expenses rose 17.7%, 22.0% and 23.3%, respectively, as the company invested in headcount, facilities and growth.
Outlook, risks and unusual items
- Management expected operating costs and R&D, sales and administrative spending to increase with growth. It anticipated further factory and equipment investment; estimated future growth capital expenditures at approximately 8%–12% of annual revenue, excluding buildings and maintenance capital.
- Management stated that cash and operating cash flow should cover working-capital and expenditure needs for at least 12 months. No specific revenue or earnings guidance was provided.
- In 2016 the company discontinued Metal Injection Molding and Magnesium Thixomolding and exited Alphaform’s resin resale business; together these activities represented about 1.6% of 2016 revenue. It recorded a $0.5 impairment loss and accelerated depreciation associated with facility moves.
- Key risks include competition and rapid technological change; execution of growth and capacity expansion; customer expectations for price, quality and turnaround; facility, website or systems interruptions; cybersecurity and protection of confidential part designs; supplier concentration; international, Brexit and currency exposure; and tax uncertainty. The company did not hedge foreign-currency exposure and said a hypothetical 10% adverse exchange-rate move could materially affect results of operations.
- The board authorized up to $50 million of share repurchases on February 9, 2017, after year-end; timing and amounts depend on market conditions. The company does not expect to pay cash dividends for the foreseeable future.
- Auditors issued unqualified opinions on the financial statements and internal control over financial reporting. The filing stated that ordinary-course litigation was not expected to have a material adverse effect.
Important facts for investors to verify
- Whether customer and revenue growth can continue despite lower average revenue per developer and a smaller share of revenue from existing customers.
- Whether gross and operating margins stabilize as capacity is utilized and lower-margin 3D printing and European operations expand.
- How much of operating cash flow reflects sustainable operating performance versus working-capital movements, tax benefits and other adjustments.
- The financial effects of currency movements, the company’s unhedged exposure, and the treatment and availability of foreign-held cash.
- Progress and returns from planned capacity, technology and sales investments, and execution of the share-repurchase authorization.